Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo

Makers of Wegovy, Ozempic and Zepbound can’t keep up with skyrocketing demand for their GLP-1 drugs, so insurance coverage isn’t important for near-term growth.
Source link